Value-based health care: issues for pharmaceutical companies
Michael Lampert, Ropes & Gray health care partner, discusses issues facing pharmaceutical companies with the move towards value-based health care models.
Trending Legal Topics Similar Videos
Donations to patient assistance charities
Laura Hoey, Ropes & Gray litigation & enforcement partner, examines the increased enforcement of donations from drug manufacturers to patient assistance charities.
Enforcement of electronic health records
Joshua Levy, co-chair of Ropes & Gray’s litigation & enforcement practice, addresses an emerging trend in the electronic health records space, where a number of companies are being investigated under the False Claims Act.
Impact of environmental, social and governance agenda on tax
Andrew Howard, Ropes & Gray tax partner, addresses tax coming out of the shadows and becoming part of an environmental, social and governance (ESG) agenda.
Behavioral sciences approach to risk management
Amanda Raad, co-chair of Ropes & Gray’s anti-corruption & international risk practice, discusses the new data-driven behavioral sciences approach to risk management.
Impact of changes at the PTAB on patent owners
Scott McKeown, Ropes & Gray IP litigation partner and chair of the firm’s Patent Trial and Appeal Board (PTAB) group, examines how some recent changes at the PTAB will benefit patent owners.
SEC activity with fixed income and credit funds
Dan O’Connor, co-leader of Ropes & Gray’s securities & futures enforcement practice, addresses the recent uptick in how the SEC is approaching issues at fixed income and credit funds.